SYNOPSIS Co-trimoxazole was found to have a predominantly bacteriostatic effect upon 28 urinary isolates of Enterobacteriaceae in nutrient broth and was never bactericidal in artificially infected urine. The components of co-trimoxazole were tested individually and trimethoprim was found to be at least as effective as co-trimoxazole in nutrient broth and in urine. Trimethoprim alone produced some bactericidal effect in urine but this was antagonized by sulphamethoxazole.
Despite the absence of a full evaluation of trimethoprim itself, a combination with sulphamethoxazole (co-trimoxazole) was introduced into general clinical use in 1968 and has been widely used since. A Swiss clinical trial showed that there was very little overall difference between trimethoprim and the combination in the treatment of urinary tract infections (Hoigne, Muller, and Schneider, 1969) . A later English investigation showed that trimethoprim was as effective as co-trimoxazole in domiciliary patients but the mixture appeared to be superior in hospital patients (Brumfitt and Pursell, 1972) . The latter results may possibly be less conclusive than they appear because hospital infection may be due to epidemics of a few organisms or to transferable antibiotic resistance within a bacterial population. Co-trimoxazole has been shown to be more effective than its components in chronic urinary tract infections caused by Enterobacteriaceae (Gleckman, 1973) . However, this last study was not representative of commonly occurring urinary infections since it involved a population with a mean age of 59 years consisting of about 48 % males.
Some of the properties initially attributed to cotrimoxazole in vitro have been found to be unpredictable. It now appears that the combination is "Present address: The Group Pathology Laboratories, The County Hospital, York, Y03 7PG.
Received for publication 8 May 1974. more often bacteriostatic rather than cidal in vitro (Kiichler and Koch, 1973; Lacey, Anderson, Lewis, and Gillespie, 1973; Lewis, Anderson, and Lacey, 1974) and that any cidal activity may be due to the trimethoprim component alone .
In order to obtain a more realistic assessment of the activity of these drugs in vitro we have studied the antibacterial activity of co-trimoxazole and its components in artificial mixtures in urine and in urine from volunteers some of whom had taken therapeutic doses of these agents. The results indicate that trimethoprim alone may be expected to be as effective as co-trimoxazole in the treatment of urinary infections.
Methods

PATIENTS AND ORGANISMS
Twenty-eight isolates of Enterobacteriaceae were obtained from 12 outpatients and 16 inpatients who had significant urinary tract infections. Specimens were obtained from five hospitals within a 20 mile radius of Bristol over a period of several weeks in order to minimize the possibility of collecting the same organism or the same plasmid-mediated resistance determinant from different patients. The organisms were identified (Cowan and Steele, 1965) as Escherichia coli, 26; atypical E. coli, one; Proteus morganii, one. Nine of these organisms were resistant to sulphamethoxazole alone and one to both trimethoprim and sulphamethoxazole. For certain experiments 24-hr collections of midstream urine from healthy individuals were treated as described above. Sulphamethoxazole, or trimethoprim, or the combination (ratio 20:1 w/w) were then added to the urine as already described test organisms was incubated with urine from a third individual who had received therapeutic doses of this agent.
Discussion
Although the study of organisms in urine described here may not relate necessarily to the natural environment, since no attempt was made to study these agents at concentrations found in kidney tissue, it was probably closer to the conditions found in urinary infections than experiments performed in nutrient broth. The main conclusion was that co-trimoxazole or its components do not produce a reliable destruction of bacteria in urine and that trimethoprim alone would appear to be as effective, and possibly more so, than the mixture. It is puzzling that trimethoprim has not been subjected to a more extensive clinical evaluation in its own right. Failure to show any difference between the response of sulphonamide-sensitive or -resistant organisms to co-trimoxazole in urine is supported by parallel findings in a clinical study of urinary tract infections (Acar, Goldstein, and Chabbert, 1973) .
Variations in the response of organisms to these various antibacterials after different periods of incubation suggest that bacterial response may be a function of the stage of growth.
The clinical significance of laboratory tests for sensitivity to these agents remains in doubt and one cannot at present improve on the observation that therapeutic results with co-trimoxazole in urinary tract infections may be largely predicted from a knowledge of sensitivity tests in vitro to trimethoprim alone (Reeves, Faiers, Pursell, and Brumfitt, 1969) .
The use of trimethoprim instead of co-trimoxazole is known to cause fewer side effects (Brumfitt and Pursell, 1972) . The possible increased chance of selecting antibiotic resistant populations by a single agent may now be largely discounted in clinical practice (Lacey et al, 1973; Lewis et al, 1974) 
